ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market size was valued at USD 41.21 Million in 2021 and is projected to reach USD 74.86 Million by the end of 2030, growing at a CAGR of 5.76% from 2023 to 2030.
There has been a significant focus on the early-stage diagnosis of infection, viral load measurement can be done using the molecular detection method, which is a driving factor supporting the growth of the ASEAN mosquito-borne infections molecular testing market. The ASEAN Mosquito-Borne Infections Molecular Testing Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Insects play a positive role in human life, but some insects significantly harm human health. One such insects are Mosquitoes that significantly harm human health because they act as disease vectors. Some diseases caused by mosquitoes have been serious health problem in society with the many losses incurred Mosquitoes such as Aedes aegypti and Aedes albopictus that became disease vectors are causing various diseases such as Dengue Haemorrhagic Fever (DHF) chikungunya, Malaria, and many others. At present, there have been many reports of diseases transmitted by mosquitoes as vectors and due to the many losses caused by the disease, effort to eradicate the disease are made. One such efforts includes the diagnosis of these diseases where the role of molecular testing comes into existence.
The region is home to dynamic systems in which social, ecological, biological, and technological processes interconnect in ways that allows the microbes to exploit new ecological niches. These processes involves population growth and movement, urbanisation, changes in food production, agriculture and land use, water and sanitation, and the effect of health systems through generation of drug resistance. Southeast Asia is home to about 600 million people residing in countries as diverse as Laos, until recently an overwhelmingly rural economy, with a GDP of USD 890 per head and Singapore, a city state with a gross domestic product (GDP) of USD 37 500 per head. Therefore, there has been a significant focus on the early-stage diagnosis of infection, viral load measurement can be done using molecular detection method, which is a driving factor supporting the growth of the ASEAN mosquito borne infections molecular testing market. The government of Laos has pledged to eliminate malaria by 2030, and despite the impact of the global COVID-19 pandemic, malaria testing numbers continue to increase in the country while the total number of cases fall. At the end of 2020 the country launched new Elimination Surveillance and Response Guidelines which further cement a commitment to proactively tracking, testing and treating every case. All these initiatives are opening the doors for various opportunities to enter the ASEAN mosquito borne infections molecular testing market.
However, the costs of preventing or controlling mosquito born infectious disease can seem high when compared to the direct public health benefits of such actions. This can be explained as Nucleic acid tests (NATs) that are known as molecular tests are required to be done in a centralized lab location and require expensive equipment and skilled personnel. Thus, the lack of awareness as well as investments are likely to hamper the growth of ASEAN mosquito borne infections molecular testing market.
To Get a Summarized Market Report By Disease Type-
Dengue accounted for the largest market share of 91.20% in 2021, with a market value of USD 33.77 Million, and are projected to grow at a CAGR of 5.89% during the forecast period. Dengue cases in the SEA region grew by 46% between 2015 and 2019, although mortality fell by 2%. The spread and distribution of the dengue mosquito vector in SEAR are caused by several different reasons. High rates of population expansion, insufficient water supplies and storage techniques, inadequate sewer, and waste management systems, an increase in international trade and tourism, global warming, modifications to public health policies, the emergence of hyper-endemicity in metropolitan areas, etc. The existing scenario of a heavy incidence of dengue cases in the SEA region is accompanied by a lack of comprehensive sustainable vector control and efficient treatment. Dengue virus RNA may typically be found by molecular tests within the first 1–7 days of an illness in symptomatic dengue virus-infected patients.
ASEAN Mosquito-Borne Infections Molecular Testing Market, By End-User
• Hospitals And Clinics• Private Commercial Laboratories• Others
To Get a Summarized Market Report By End Users-
Hospitals and Clinics accounted for the largest market share of 54.51% in 2021, with a market value of USD 20.15 Million, and are projected to grow at a CAGR of 5.77% during the forecast period. Many hospital executives are currently contemplating if opening a molecular diagnostics laboratory is the best course of action for their organizations and are analyzing potential funding models to support molecular diagnostic testing. Potential revenue generation and cost avoidance are important factors to take into account. The reimbursements for molecular tests are more alluring, and their net revenues far outpace those of clinical chemistry panels, immunoassays, and culture tests. A significant number of expensive send-out tests can be eliminated by purchasing a molecular testing system.
ASEAN Mosquito-Borne Infections Molecular Testing Market, By Geography
In the global market split, Philippines is dominating region-wise while automated is leading according to type. The Philippines is a string of over 7,100 islands situated in South-Eastern Asia between the South China Sea and the Pacific Ocean. The Philippines, being a fertile, tropical and biodiverse land has evolved as a centre for vector-borne diseases burdening the healthcare sector of the country. Main diseases that are largely spreading their presence in the country are Malaria, Dengue, Lymphatic filariasis, Schistosomiasis and Japanese encephalitis.
Key Players
The presence of prominent ASEAN Mosquito-Borne Infections Molecular Testing market players such as InBios International Inc, NovaTec Immundiagnostica GmbH, Abbott Laboratories, Abnova Corporation, Thermo Fisher Scientific Inc., Certest Biotech SL, F. Hoffmann-La Roche Ltd, OriGene Technologies Inc., and Quest Diagnostics.
Key Developments
• September 2018, InBios received 510k marketing clearance from the FDA for its DENV Detect NS1 ELISA kit for many infections disease.
This antigen detection assay provides presumptive diagnosis of dengue virus from serum samples taken from patients within the first seven days of clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. The NS1 kit correctly identified 86.6% of patients confirmed positive for dengue NS1 antigen and 97.8% of negative confirmed patient specimens.
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements a
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
